| |
| |
| |
| |
| | | |
|
PR:000050281 |
rep gene proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| | | | |
|
PR:000050282 |
ORF1a proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| | | | |
|
PR:000050283 |
ORF1ab proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| |
| | | | | |
|
PR:000050286 |
proofreading exoribonuclease nsp14 (SARS-CoV-2) | | | | | |
| | | | | |
|
PR:000050287 |
uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | | |
|
PR:000050262 |
severe acute respiratory syndrome coronavirus 2 protein | | | | | |
| |
| | | | | |
|
PR:000050281 |
rep gene proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| | | | | | |
|
PR:000050282 |
ORF1a proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| | | | | | |
|
PR:000050283 |
ORF1ab proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| |
| | | | | | | |
|
PR:000050286 |
proofreading exoribonuclease nsp14 (SARS-CoV-2) | | | | | |
| | | | | | | |
|
PR:000050287 |
uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |